PT  - JOURNAL ARTICLE
AU  - Umoren, Rachel
AU  - Asangansi, Ime
AU  - Afenir, Dillon
AU  - Bresnahan, Brian W.
AU  - Kotler, Annabelle
AU  - White, Cailin
AU  - Cook, Matt
AU  - Lowman, Casey
AU  - Berkelhamer, Sara
TI  - The Data Burden of Digital Learning
AID  - 10.1101/2024.08.23.24312503
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.08.23.24312503
4099  - http://medrxiv.org/content/early/2024/08/23/2024.08.23.24312503.short
4100  - http://medrxiv.org/content/early/2024/08/23/2024.08.23.24312503.full
AB  - The costs of participating in training programs that rely on video conferencing vary by mechanics of use and the specific platform. We proposed practical solutions to limiting costs in low resource settings with the use of video conferencing calls. Scenarios in which facilitators have their video on and expect learners to participate with continuous video result in the greatest data burden, while use of intermittent video by both facilitator and learners can significantly lower data use, and thus costs. The choice of a platform also impacts teleprogramming, with creative options for use of lower cost platforms to reduce participant and training organization costs. These might include sharing educational content or video via chat groups and limiting conference to audio alone. In the context of COVID-19 where virtual meetings have become prevalent, it is critical that data burden is considered by program directors and funders. Looking forward, hybrid training that includes virtual and in-person training will likely become the norm in global health settings, but achieving this model will still require thoughtful consideration of data costs. Further, our findings are relevant to many other fields and advocate for evaluation of costs and data burden along with the growing use of teleprogramming in these settings.Author Summary The COVID-19 pandemic restricted travel and in-person gatherings. These restrictions also impacted access to important in-person training programs for healthcare workers, especially in areas where financial resources are limited. However, one positive impact of the pandemic has been improved access and experience with video conferencing tools (like Zoom) for many healthcare training programs. These video conferencing tools provide a way to complete essential training when in-person options may be limited. However, video-based training can have significant costs including internet data costs, mobile device costs, and healthcare worker professional time. Our study examined the data costs associated with video conferencing using several video conferencing applications across 5,554 mobile data plans in 228 countries. We found that costs are highest when trainers have their video on and learners participate with video on throughout the training. Intermittent video use by both trainers and learners can significantly lower costs. We also found that using lower-cost video-conferencing tools may help reduce costs. Additionally, there are training methods that can reduce costs including sharing educational content or video via chat groups and limiting conferences to audio only. Virtual training is a powerful and common tool in healthcare settings, but it is essential to consider costs, especially in areas with limited resources.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data are included in the manuscript. Data available on request to Rachel Umoren rumoren@uw.edu.